Best-selling novelist Jane Fallon has publicly disclosed that she has been diagnosed with breast cancer and is scheduled to undergo surgery later this month. The 65-year-old author, who is the long-term partner of renowned comedian Ricky Gervais, shared this personal health update on her Instagram account on Thursday, March 12, 2026.
Early Detection Through Routine Screening
Fallon's diagnosis was identified at an early stage, which medical professionals have indicated carries an excellent prognosis for recovery. The cancer was discovered during a routine mammogram conducted late last year, despite Fallon experiencing no noticeable symptoms at the time.
Diagnostic Process and Medical Care
A radiographer initially spotted something unusual during the mammogram, prompting a series of further diagnostic tests. These included additional mammograms, biopsies, and an MRI scan to confirm the diagnosis and assess the extent of the condition.
In her social media post, Fallon reassured her followers and fans that she is receiving what she described as "incredible care" from her medical team. She expressed a positive outlook, stating that she is ready to get the necessary treatment "over with" and move forward with her recovery.
Personal Life and Career Context
Jane Fallon is a celebrated author known for her best-selling novels, and she has been in a long-term relationship with comedian Ricky Gervais for many years. The couple has previously been open about their decision not to have children, with Fallon stating she "never" wanted to become a parent.
Her diagnosis comes as a reminder of the importance of regular health screenings, particularly for conditions like breast cancer where early detection can significantly improve treatment outcomes. Fallon's openness about her experience may help raise awareness and encourage others to prioritize their health check-ups.
The medical community emphasizes that routine mammograms are crucial for detecting breast cancer in its early stages, often before symptoms appear. Fallon's case illustrates how these screenings can lead to timely intervention and better prognosis, even when individuals feel completely healthy.
